Enlivex Randomizes 135 Patients in Allocetra Knee Osteoarthritis Trial
Enlivex said 135 of the planned 182 patients have been randomized and administered the first injection in its Phase 2b trial of Allocetra for age-related moderate-to-severe knee osteoarthritis.
Story updates
12:04:30 PM UTC
SquawkNews
• 135 patients, out of a total planned 182, have been randomized and were administered the first injection of AllocetraTM; enrollment actively ongoing at clinical sites in the United States and in Europe• Topline six-month data expected by mid-2027• Phase 2b builds on positive three- and six-month…
12:04:54 PM UTC
SquawkNews
Enlivex randomized 135 of a planned 182 patients and dosed first injections in its global Phase 2b Allocetra knee OA trial, with topline six-month data expected by mid-2027.Material DetailsContext by AI AnalystThis is a mid-study operational update that advances an RMAT-designated OA program toward…